Literature DB >> 11741243

Conditionally immortalized brain capillary endothelial cell lines established from a transgenic mouse harboring temperature-sensitive simian virus 40 large T-antigen gene.

K Hosoya1, K Tetsuka, K Nagase, M Tomi, S Saeki, S Ohtsuki, H Takanaga, N Yanai, M Obinata, A Kikuchi, T Okano, T Terasaki.   

Abstract

Five immortalized brain capillary endothelial cell lines (TM-BBB1-5) were established from 3 transgenic mice harboring temperature-sensitive simian virus 40 large T-antigen gene (Tg mouse). These cell lines expressed active large T-antigen and grew well at 33 degrees C with a doubling time of about 20 to 30 hours. TM-BBBs also grew at 37 degrees C but not at 39 degrees C. However, growth was restored when the temperature of the culture was lowered to 33 degrees C. Although significant amounts of large T-antigen were shown to be present in the cell culture at 33 degrees C, there was less of this complex at 37 degrees C and 39 degrees C. TM-BBBs expressed the typical endothelial marker, von Willebrand factor, and exhibited acetylated low-density lipoprotein uptake activity. The alkaline phosphatase and gamma-glutamyltranspeptidase activity in TM-BBBs were -10% and 50% to 80% of brain capillary fraction of normal mice, respectively. D-mannitol transport in the both apical-to-basal and basal-to-apical directions across the TM-BBB was 2-fold greater than for inulin. TM-BBBs were found to express GLUT-1 but not GLUT-3, and exhibited concentration-dependent 3-O-methyl-D-glucose (3-OMG) uptake activity with a Michaelis-Menten constant of 6.59 +/- 1.16 mmol/l. Moreover, P-glycoprotein (P-gp) with a molecular weight of -170 kDa was expressed in all TM-BBBs. Both mdr1a and mdr1b mRNA were detected in TM-BBB4 using reverse transcription-polymerase chain reaction (RT-PCR) analysis. [3H]-Cyclosporin A uptake by TM-BBB was significantly increased in the presence of 100 micromol/l verapamil and vincristine, suggesting that TM-BBB exhibits efflux transport activity via P-gp. In conclusion, conditional brain capillary endothelial cell lines were established from Tg mice. This cell line expresses endothelial markers and transporters at the BBB and is able to regulate cell growth, due to the amount of active large T-antigen in the cell, by changing the culture temperature.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11741243      PMCID: PMC2761138          DOI: 10.1208/ps020328

Source DB:  PubMed          Journal:  AAPS PharmSci        ISSN: 1522-1059


  33 in total

Review 1.  Conditionally immortalized cell lines with differentiated functions established from temperature-sensitive T-antigen transgenic mice.

Authors:  M Obinata
Journal:  Genes Cells       Date:  1997-04       Impact factor: 1.891

2.  Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and in situ hybridization.

Authors:  W M Pardridge; R J Boado; C R Farrell
Journal:  J Biol Chem       Date:  1990-10-15       Impact factor: 5.157

3.  Hepatocyte cell lines established from transgenic mice harboring temperature-sensitive simian virus 40 large T-antigen gene.

Authors:  N Yanai; M Suzuki; M Obinata
Journal:  Exp Cell Res       Date:  1991-11       Impact factor: 3.905

4.  FISH mapping of the porcine vWF gene to chromosome 5q21 extends synteny homology with human chromosome 12.

Authors:  A Sjöberg; W T Seaman; D A Bellinger; T R Griggs; T C Nichols; B P Chowdhary
Journal:  Hereditas       Date:  1996       Impact factor: 3.271

5.  Novel smooth muscle cell lines from transgenic mice harboring temperature-sensitive SV40 large T-antigen gene. Temperature-dependent expression of smooth muscle myosin heavy chain-1 and calponin genes.

Authors:  K Hasegawa; E Arakawa; S Oda; N Yanai; M Obinata; Y Matsuda
Journal:  J Mol Cell Cardiol       Date:  1997-08       Impact factor: 5.000

6.  Isolation and primary culture of rat cerebral microvascular endothelial cells for studying drug transport in vitro.

Authors:  N Ichikawa; K Naora; H Hirano; M Hashimoto; S Masumura; K Iwamoto
Journal:  J Pharmacol Toxicol Methods       Date:  1996-09       Impact factor: 1.950

7.  A pharmacokinetic analysis program (multi) for microcomputer.

Authors:  K Yamaoka; Y Tanigawara; T Nakagawa; T Uno
Journal:  J Pharmacobiodyn       Date:  1981-11

8.  Comparison of in vitro and in vivo models of drug transcytosis through the blood-brain barrier.

Authors:  W M Pardridge; D Triguero; J Yang; P A Cancilla
Journal:  J Pharmacol Exp Ther       Date:  1990-05       Impact factor: 4.030

9.  Establishment of gastric surface mucous cell lines from transgenic mice harboring temperature-sensitive simian virus 40 large T-antigen gene.

Authors:  N Sugiyama; Y Tabuchi; T Horiuchi; M Obinata; M Furusawa
Journal:  Exp Cell Res       Date:  1993-12       Impact factor: 3.905

10.  Occludin as a possible determinant of tight junction permeability in endothelial cells.

Authors:  T Hirase; J M Staddon; M Saitou; Y Ando-Akatsuka; M Itoh; M Furuse; K Fujimoto; S Tsukita; L L Rubin
Journal:  J Cell Sci       Date:  1997-07       Impact factor: 5.285

View more
  13 in total

1.  Culture of murine brain microvascular endothelial cells that maintain expression and cytoskeletal association of tight junction-associated proteins.

Authors:  Li Song; Joel S Pachter
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 Jul-Aug       Impact factor: 2.416

Review 2.  Brain-to-blood transporters for endogenous substrates and xenobiotics at the blood-brain barrier: an overview of biology and methodology.

Authors:  Tetsuya Terasaki; Sumio Ohtsuki
Journal:  NeuroRx       Date:  2005-01

Review 3.  Permeability studies on in vitro blood-brain barrier models: physiology, pathology, and pharmacology.

Authors:  Máiria A Deli; Csongor S Abrahám; Yasufumi Kataoka; Masami Niwa
Journal:  Cell Mol Neurobiol       Date:  2005-02       Impact factor: 5.046

Review 4.  Methodologies to assess drug permeation through the blood-brain barrier for pharmaceutical research.

Authors:  Céline Passeleu-Le Bourdonnec; Pierre-Alain Carrupt; Jean Michel Scherrmann; Sophie Martel
Journal:  Pharm Res       Date:  2013-06-26       Impact factor: 4.200

Review 5.  Active efflux across the blood-brain barrier: role of the solute carrier family.

Authors:  Hiroyuki Kusuhara; Yuichi Sugiyama
Journal:  NeuroRx       Date:  2005-01

6.  Atrial natriuretic peptide is eliminated from the brain by natriuretic peptide receptor-C-mediated brain-to-blood efflux transport at the blood-brain barrier.

Authors:  Shingo Ito; Sumio Ohtsuki; Yuki Katsukura; Miho Funaki; Yusuke Koitabashi; Akihiko Sugino; Sho Murata; Tetsuya Terasaki
Journal:  J Cereb Blood Flow Metab       Date:  2010-07-14       Impact factor: 6.200

7.  Occludin as direct target for glucocorticoid-induced improvement of blood-brain barrier properties in a murine in vitro system.

Authors:  Carola Förster; Christine Silwedel; Nikola Golenhofen; Malgorzata Burek; Silke Kietz; Joachim Mankertz; Detlev Drenckhahn
Journal:  J Physiol       Date:  2005-03-24       Impact factor: 5.182

8.  Efficient in vivo delivery of siRNA into brain capillary endothelial cells along with endogenous lipoprotein.

Authors:  Hiroya Kuwahara; Kazutaka Nishina; Kie Yoshida; Tomoko Nishina; Mariko Yamamoto; Yukari Saito; Wenying Piao; Masayuki Yoshida; Hidehiro Mizusawa; Takanori Yokota
Journal:  Mol Ther       Date:  2011-09-13       Impact factor: 11.454

9.  BMP signaling through BMPRIA in astrocytes is essential for proper cerebral angiogenesis and formation of the blood-brain-barrier.

Authors:  Runa Araya; Moeko Kudo; Masako Kawano; Katsuyoshi Ishii; Tsutomu Hashikawa; Takuji Iwasato; Shigeyoshi Itohara; Tetsuya Terasaki; Atsuhiko Oohira; Yuji Mishina; Masahisa Yamada
Journal:  Mol Cell Neurosci       Date:  2008-04-20       Impact factor: 4.314

10.  Transport characteristics of guanidino compounds at the blood-brain barrier and blood-cerebrospinal fluid barrier: relevance to neural disorders.

Authors:  Masanori Tachikawa; Ken-Ichi Hosoya
Journal:  Fluids Barriers CNS       Date:  2011-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.